Joanne Curley Vera Therapeutics, Inc. (VERA) insider trading activity

VERA Quotes by TradingView

Joanne Curley is Chief Development Officer of Vera Therapeutics, Inc.. Currently has a direct ownership of 26,962 shares of VERA, which is worth approximately $1.32 Million. The most recent transaction as insider was on Jul 19, 2022, when has been sold 11,444 shares (Class A Common Stock) at a price of $16.28 per share, resulting in proceeds of $186,308. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27K
0% 3M change
0% 12M change
Total Value Held $1.32 Million

Joanne Curley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 19 2022
SELL
Open market or private sale
$186,308 $16.28 p/Share
11,444 Reduced 38.51%
18,273 Class A Common Stock
Jul 19 2022
BUY
Exercise of conversion of derivative security
$53,100 $4.64 p/Share
11,444 Added 38.5%
18,281 Class A Common Stock
Jul 14 2022
SELL
Open market or private sale
$137,926 $15.15 p/Share
9,104 Reduced 33.25%
18,273 Class A Common Stock
Jul 14 2022
BUY
Exercise of conversion of derivative security
$18,427 $2.9 p/Share
6,354 Added 18.84%
27,377 Class A Common Stock
Jul 07 2022
SELL
Open market or private sale
$145,473 $15.05 p/Share
9,666 Reduced 31.5%
21,023 Class A Common Stock
Jul 07 2022
BUY
Exercise of conversion of derivative security
$32,485 $4.64 p/Share
7,001 Added 20.47%
27,202 Class A Common Stock
Jun 22 2022
SELL
Open market or private sale
$23,206 $15.02 p/Share
1,545 Reduced 6.12%
23,688 Class A Common Stock
Jun 22 2022
BUY
Exercise of conversion of derivative security
$7,892 $6.37 p/Share
1,239 Added 4.68%
25,233 Class A Common Stock
Jun 17 2022
SELL
Open market or private sale
$88,599 $15.05 p/Share
5,887 Reduced 19.7%
23,994 Class A Common Stock
Jun 17 2022
BUY
Exercise of conversion of derivative security
$21,748 $4.64 p/Share
4,687 Added 14.11%
28,535 Class A Common Stock
May 31 2022
SELL
Open market or private sale
$6,088 $15.22 p/Share
400 Reduced 1.56%
25,194 Class A Common Stock
May 31 2022
BUY
Exercise of conversion of derivative security
$2,548 $6.37 p/Share
400 Added 1.54%
25,594 Class A Common Stock

Also insider at

VTGN
VistaGen Therapeutics, Inc. Healthcare
JC

Joanne Curley

Chief Development Officer
Brisbane, CA

Track Institutional and Insider Activities on VERA

Follow Vera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VERA shares.

Notify only if

Insider Trading

Get notified when an Vera Therapeutics, Inc. insider buys or sells VERA shares.

Notify only if

News

Receive news related to Vera Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VERA